Target intelligence / Profile preview

Energy restriction (ER)

Target
ER
Molecular classification
Physiological process, Dietary intervention, Metabolic state
01

Overview

Energy restriction, widely known as caloric restriction, is a dietary intervention that involves reducing total calorie intake without causing malnutrition. It is not a single molecular target or receptor but rather a systemic physiological state that triggers a complex network of metabolic and cellular adaptations. This state is characterized by the downregulation of growth-promoting pathways, such as the Mechanistic Target of Rapamycin (mTOR) and Insulin/IGF-1 signaling, and the upregulation of energy-sensing and survival pathways, including Adenosine Monophosphate-activated Protein Kinase (AMPK) and Sirtuins (National Institute on Aging, 2023). These molecular shifts promote cellular maintenance, enhance DNA repair, and induce autophagy, which collectively contribute to delayed biological aging and a reduced incidence of chronic diseases such as cancer, diabetes, and neurodegeneration (Madeo et al., Nature Reviews Drug Discovery, 2019). In the context of drug discovery, energy restriction serves as the gold-standard physiological model for longevity and metabolic health. Researchers focus on developing 'caloric restriction mimetics' (CRMs), which are pharmacological agents designed to induce the beneficial biochemical effects of energy restriction without requiring a reduction in food intake. Common examples include Metformin, which activates AMPK, and Rapamycin, which inhibits mTOR. While energy restriction itself is a lifestyle intervention, the pathways it activates are primary therapeutic targets for treating metabolic syndrome and age-related pathologies (Fontana et al., Science, 2010).

Other names
Caloric restrictionCalorie restrictionDietary restrictionCREnergy intake restriction
02

Mechanism of action

Energy restriction functions by modulating nutrient-sensing pathways, specifically through the activation of Adenosine Monophosphate-activated Protein Kinase (AMPK) and Sirtuins (e.g., SIRT1), and the simultaneous inhibition of the Mechanistic Target of Rapamycin (mTOR) and the Insulin/IGF-1 signaling axis (Fontana & Partridge, Cell, 2015).

03

Biological functions

Metabolic reprogrammingAutophagy inductionHormesisInsulin sensitivity enhancementReduction of oxidative stressLongevity regulationStem cell maintenance
04

Disease associations

ObesityType 2 diabetesCardiovascular diseaseCancerNeurodegenerative diseaseAging-related metabolic decline
05

Safety considerations

Risk of malnutrition or micronutrient deficienciesLoss of lean muscle mass (sarcopenia)Reduced bone mineral densityPotential for reproductive dysfunction or hormonal imbalancesIncreased sensitivity to cold temperaturesPsychological stress or disordered eating patterns
06

Interacting drugs

Metformin

6 more in the full profile.

07

Biomarkers

Reduced circulating Insulin-like Growth Factor 1 (IGF-1)Decreased fasting blood glucoseLowered fasting insulin levelsIncreased Adiponectin levelsReduced Glycated hemoglobin (HbA1c)Increased AMPK phosphorylation

Beyond the preview

Go deeper on Energy restriction (ER).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Energy restriction (ER).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call